OPTIMAL>60, Improvement of Therapy of Elderly Patients With CD20+ DLBCL Using Rituximab Optimized and Liposomal Vincristine

This study is currently recruiting participants.
Verified October 2012 by University Hospital, Saarland
Sponsor:
Collaborator:
German High-Grade Non-Hodgkin's Lymphoma Study Group
Information provided by (Responsible Party):
University Hospital, Saarland
ClinicalTrials.gov Identifier:
NCT01478542
First received: November 18, 2011
Last updated: October 16, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2019
  Estimated Primary Completion Date: October 2016 (Final data collection date for primary outcome measure)